1. |
Abad CL, Lahr BD, Razonable RR. Epidemiology and risk factors for infection after living donor liver transplantation. Liver Transpl, 2017, 23(4): 465-477.
|
2. |
郑树森, 俞军, 张武. 肝移植在中国的发展现状. 临床肝胆病杂志, 2014, 30(1): 2-4.
|
3. |
中国肝移植注册. https://www.cltr.org.
|
4. |
Singh N, Gayowski T, Wagener M, et al. Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants. Transplantation, 1994, 58(7): 774-778.
|
5. |
Winston DJ, Emmanouilides C, Busuttil RW. Infections in liver transplant recipients. Clin Infect Dis, 1995, 21(5): 1077-1089.
|
6. |
Kawecki D, Chmura A, Pacholczyk M, et al. Bacterial infections in the early period after liver transplantation: etiological agents and their susceptibility. Med Sci Monit, 2009, 15(12): C628-C637.
|
7. |
Rayes N, Seehofer D, Theruvath T, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation—a randomized, double-blind trial. Am J Transplant, 2005, 5(1): 125-130.
|
8. |
周英凤, 钟婕, 李丽, 等. 构建证据生态系统, 推动循证护理实践发展. 护士进修杂志, 2019, 34(3): 193-197.
|
9. |
朱政, 胡雁, 邢唯杰, 等. 不同类型循证问题的构成. 护士进修杂志, 2017, 32(21): 1991-1994.
|
10. |
Dicenso A, Bayley L, Haynes RB. Accessing pre-appraised evidence: fine-tuning the 5S model into a 6S model. Evid Based Nurs, 2009, 12(4): 99-101.
|
11. |
Murad MH, Montori VM, Ioannidis JP, et al. How to read a systematic review and meta-analysis and apply the results to patient care: users’ guides to the medical literature. JAMA, 2014, 312(2): 171-179.
|
12. |
The Joanna Briggs Institute (JBI). (2017-07-15) [2017-11-24]. http://joannabriggs.org/research/critical-appraisal-tools.html.
|
13. |
Chávez-Tapia NC, González-Rodrígueza L, Jeong M, et al. Current evidence on the use of probiotics in liver diseases. J Funct Foods, 2015, 17: 137-151.
|
14. |
魏晓晨, 朱立勤, 王春革. 联用益生菌和益菌生对肝移植患者术后细菌感染影响的系统评价. 中国新药杂志, 2013, 22(23): 2779-2785.
|
15. |
王有军, 张翠萍. 益生菌对肝移植术后患者感染的影响及相关因素 Meta 分析. 中国微生态学杂志, 2017, 29(11): 1261-1264.
|
16. |
Eguchi S, Takatsuki M, Hidaka M, et al. Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study. Am J Surg, 2011, 201(4): 498-502.
|
17. |
Zhang Y, Chen J, Wu J, et al. Probiotic use in preventing postoperative infection in liver transplant patients. Hepatobiliary Surg Nutr, 2013, 2(3): 142-147.
|
18. |
刘海潮, 张水军, 郭文治. 益生菌应用于肝移植术后患者的临床意义. 中国普通外科杂志, 2013, 22(1): 71-74.
|
19. |
Motanya J. Evaluation of the safety of probiotic use in transplant recipients. Jane Gervasio (Butler University), 2014.
|
20. |
The Joanna Briggs Institute Levels of Evidence and Grades of Recommendation Working Party. Supporting Document for the Joanna Briggs Institute levels of Evidence and Grades of Recommendation. The Joanna Briggs Institute. 2014. http://joannabriggs.org/jbi-approach.html#tabbed-nav-Levels-of-Evidence.
|